Relationships in Medical Technology
Navigation Links
Relationships in Medical Technology
... athletic experiences. This helps them develop positive and healthy relationships within their youth sports community. By exploring this new beverage ... at Buffalo , Buffalo, NY. Dr. Miller focuses on the gender-specific relationships among problem behaviors and athletic involvement, with particular ...
... Polymorphism . ALP Life Sciences, LLC is currently evaluating strategic relationships in the area of principal investigators, clinical trial facilities, medical ... opportunities for therapy, diagnostics and drug metabolism testing. relationships with medical research foundations, public institutes of health, and life ...
... mean change in FVC volume and Six-Minute Walk Test distance. Dose relationships In the CAPACITY 2 study, patients were randomized 2:2:1 to receive a ... dose of pirfenidone in CAPACITY 2 was included to explore dose-effect relationships in a descriptive fashion. Dr. Noble reported at the ATS meeting data on ...
... disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant ...
... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
... business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense ...
... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered in New York City. ...
... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
... with large biotechnology or pharmaceutical companies to further develop VIA-2291; -- our ability to form and maintain collaborative relationships to develop and commercialize our product candidates; -- general economic and business conditions; and -- the other risks described under Item ...
... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates and for the Company, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered ...
... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates and for the Company, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered ...
... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates and for the Company, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered ...
... inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. For a further discussion ...
... business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense ...
... as well as site selection, patient recruitment, data analysis, non-clinical evaluation, and IND/NDA submissions. PAREXEL leverages the experience and relationships its experts have with leading cancer centers and key opinion leaders in its ongoing collaborative efforts. PAREXEL applies a proven, ...
... contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities ...
... Doctors, parents, and the health care system should be aware of these babies' specialized health needs. This study sought to quantify the relationships between neonatal characteristics and the occurrence of RSV infection requiring medical attention in the first year of life. The study consisted ...
... is also forming a distinguished advisory board, consisting of thought leaders from top academic eye institutions around the country. Collaborative relationships with academic, government, and pharmaceutical industry research centers will be established to facilitate accelerated drug innovation, timely ...
... contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities ...
... pending or future government investigations, lawsuits or private actions, the competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in "Business" in Part I, Item 1, "Risk Factors" and "Cautionary ...
... necessary funding, regulatory approvals and qualifications, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities ...
... the Corporate Integrity Agreement through 2012; the impact of our enhanced healthcare compliance global initiatives and business practices on our relationships with customers and consultants, our market share and our overall financial performance; the success of our quality initiatives; the outcome of the ...
... in the forward-looking statements or historical experience include risks and uncertainties, including the failure by Novavax to secure and maintain relationships with collaborators; risks relating to the early stage of Novavax's product candidates under development; uncertainties relating to commencing ...
... in the forward-looking statements or historical experience include risks and uncertainties, including the failure by Novavax to secure and maintain relationships with collaborators; risks relating to the early stage of Novavax's product candidates under development; uncertainties relating to commencing ...
... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as Amgen may have believed at the time of entering into ...
... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
... Polymorphism . ALP Life Sciences, LLC is currently evaluating strategic relationships in the area of principal investigators, clinical trial facilities, medical ... opportunities for therapy, diagnostics and drug metabolism testing. relationships with medical research foundations, public institutes of health, and life ...
... mean change in FVC volume and Six-Minute Walk Test distance. Dose relationships In the CAPACITY 2 study, patients were randomized 2:2:1 to receive a ... dose of pirfenidone in CAPACITY 2 was included to explore dose-effect relationships in a descriptive fashion. Dr. Noble reported at the ATS meeting data on ...
American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics'
... confirmed victims of child abuse or sufferers of accidental trauma, clear relationships between injury type, child age and the presence of abuse became apparent. ... also develop a torn rotator cuff. This risk extends out to third-cousin relationships (Third cousins are the great-great-grandchildren of one's ...... disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant ...
Regular Yoga Practice Is Associated With Mindful Eating
... dietary behavior. "Beyond calories and diets, mindful eating takes a more holistic approach that can empower individuals to build positive relationships with food and eating," said first author Celia Framson, M.P.H., R.D., C.D., a former graduate student of Kristal's - and former yoga teacher - who ...... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
... type 2 diabetes. In addition to our clinical programs, we have active programs in many different therapeutic areas as well as established academic relationships with industry and academic leaders that expand our research capabilities. With the efficiency of our drug discovery technology we can broadly ...... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
... business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense ...
S.C. Medical Home Pilot for Diabetes Enrolls 1,110
... and medical societies." "The goal is to reduce the disconnects in health care, improve quality of life for the patient, create tighter relationships and better communications, and add for the first time a focus on measurement of quality and continuous improvement of clinical outcomes. We're ...Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
... to health care professionals and the public; Communicating with government bodies, and other relevant interest groups; and Building relationships with leading researchers and research institutions and supporting collaboration research in the area of probiotics and intestinal microbiota. ...Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
... the Corporate Integrity Agreement through 2012; the impact of our enhanced healthcare compliance global initiatives and business practices on our relationships with customers and consultants, our market share and our overall financial performance; the success of our quality initiatives; the outcome of the ...... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered in New York City. ...
... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
... with large biotechnology or pharmaceutical companies to further develop VIA-2291; -- our ability to form and maintain collaborative relationships to develop and commercialize our product candidates; -- general economic and business conditions; and -- the other risks described under Item ...
Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat
... player in seeds and traits," said Sheldon Richardson, chairman and CEO of W3. "With Dow AgroSciences as our partner, we can leverage customer relationships within the food chain and their marketing and commercialization expertise. Our four decades of plant breeding experience brings a wide diversity of ...... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates and for the Company, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered ...
... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates and for the Company, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered ...
... 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates and for the Company, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered ...
... inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. For a further discussion ...
... business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense ...
... as well as site selection, patient recruitment, data analysis, non-clinical evaluation, and IND/NDA submissions. PAREXEL leverages the experience and relationships its experts have with leading cancer centers and key opinion leaders in its ongoing collaborative efforts. PAREXEL applies a proven, ...
One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
... (OTC), affiliated with the Incubator Program and the Rensselaer Technology Park, helps the Institute protect intellectual property and forges relationships with industry to bring Rensselaer's discoveries to the marketplace. The OTC also contributes to the local economy by spinning off new companies that ...Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
... made to physicians by its U.S. pharmaceutical, medical device and diagnostics companies. "We are in favor of greater transparency regarding the relationships between healthcare companies and physicians," said Johnson & Johnson chairman and CEO William C. Weldon. "We continue to believe such ...... contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities ...
... Doctors, parents, and the health care system should be aware of these babies' specialized health needs. This study sought to quantify the relationships between neonatal characteristics and the occurrence of RSV infection requiring medical attention in the first year of life. The study consisted ...
... is also forming a distinguished advisory board, consisting of thought leaders from top academic eye institutions around the country. Collaborative relationships with academic, government, and pharmaceutical industry research centers will be established to facilitate accelerated drug innovation, timely ...
Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip
... in the Company's business operations; our ability to keep pace with technological advances; significant competition in the biomedical business; our relationships with key suppliers and customers; quality and consumer acceptance of newly introduced products; market volatility; non-availability of product; ...Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
... in an effort to maximize the global reach for the PCA3 prostate cancer test, DiagnoCure and Gen-Probe have agreed on terms to develop key distributor relationships in countries where it is commercially more effective to do so, such as in Japan, Asia, Israel, South Africa and others. In a separate press ...... contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities ...
... pending or future government investigations, lawsuits or private actions, the competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in "Business" in Part I, Item 1, "Risk Factors" and "Cautionary ...
... necessary funding, regulatory approvals and qualifications, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities ...
... the Corporate Integrity Agreement through 2012; the impact of our enhanced healthcare compliance global initiatives and business practices on our relationships with customers and consultants, our market share and our overall financial performance; the success of our quality initiatives; the outcome of the ...
Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis
... Certain of these risks and uncertainties may include, but are not limited to, competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors described in the Quest Diagnostics Incorporated 2007 Form 10-K and ...... in the forward-looking statements or historical experience include risks and uncertainties, including the failure by Novavax to secure and maintain relationships with collaborators; risks relating to the early stage of Novavax's product candidates under development; uncertainties relating to commencing ...
... in the forward-looking statements or historical experience include risks and uncertainties, including the failure by Novavax to secure and maintain relationships with collaborators; risks relating to the early stage of Novavax's product candidates under development; uncertainties relating to commencing ...
... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as Amgen may have believed at the time of entering into ...
Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
... including for the development of our products; effectiveness of our sales force; competition and its effect on pricing, spending, third-party relationships and revenues; dependence on third parties for supplies, particularly for histrelin, manufacturing, marketing, and clinical trials; risks associated ...... product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into ...
Other ContentsintermittentintermittentintermittentintermittentintermittentintermittentinsulinomainspectioninspectioninspectioninspectionintentionalintentionalintentionalinternetinternetinternetinternetcystitiscystitisintraintraintoxicationintoxicationOther Tags
(Date:11/24/2009)...pus Research Institute (LRI) today named 12 new gr... million, recognize innovative work across a broad... their creativity, novelty, and potential to drive..., and cure the complex disease of systemic lupus. ... lupus researchers across the nation and include i...
(Date:11/24/2009)...omic-level action of a remarkable class of ring-sh...ers with the Lawrence Berkeley National Laboratory...rystallography beamline at the Advanced Light Sour...in gene expression and replication, and are vital ...s infectious agents, such as the human papillomavi...
(Date:11/24/2009)...constitutes fish food is a matter of debate. A hig...h get almost 50 percent of their carbon from trees...n the terrestrial and aquatic ecosystems. , But ...ws this is not likely to be true. Algae provide a ...according to research published this week in the ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Lymphoma Research Foundation announces recipients of CLL SLL Research Initiative grants 60249 1Lymphoma Research Foundation announces recipients of CLL SLL Research Initiative grants 60249 2Next generation microcapsules deliver chemicals on demand 10562 1UD start up company prepares to commercialize novel detector for medical military applications 10557 1UD start up company prepares to commercialize novel detector for medical military applications 10557 2UD start up company prepares to commercialize novel detector for medical military applications 10557 3UD start up company prepares to commercialize novel detector for medical military applications 10557 4(Date:11/27/2009)...wire-USNewswire/ -- Preventing disease is the goal...ry year, new vaccines are being added to assist in...unity for the same period of time? And, if not, wh...mmunity strong? ,, In this month,s issue of P...Pediatrics, Michael Pichichero MD, Director of the...
(Date:11/27/2009)..., economic burdens, study predicts , , F...eople with diabetes in the United States is expect...redicts. , That would bring the total by 2034 t...rom 23.7 million today. , , At the same time, th...e, the study also warns, rising from an estimated ...
(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...
(Date:11/26/2009)... to strains or worse , , THURSDAY, Nov. ...with stuffing your turkey full to bursting, but yo...itcase as you pack for holiday trips. , More th...ital emergency rooms, doctors, offices, clinics an...uries, such as muscle strains, pulls and tears, ac...
(Date:11/26/2009)...ons announces a highly effective and unconventiona...to make an economic recovery. , ...he type of challenge that could send ailing holida...vid Benton, business growth expert and author of t...The Rfactor Intensive . “Fear is one of th...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2[0] Why Some Vaccines May Require A Booster[0] Diabetes Cases Expected to Double in 25 Years[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store[2] Pack Right for the Holidays to Avoid the ER[1] Pharmacist Injects Cure for Ailing Businesses
HypoplasticHypospadiasHypoparathyroidismHypopituitarismHypotensionHyposensitizationHypothalamicHypothermiaHypothyroidHypotoniaHypovolemicHypoventilationHysterosalpingographyIatrogenic
Other Tagsadvanced 2advanced 3advanced 4advanced 5advanced 6advanced 7advanced 8advanced 9advanced 10innovative 2innovative 3innovative 4innovative 5innovative 6innovative 7innovative 8innovative 9innovative 10lasers 2psychiatric 2psychiatric 3psychiatric 4psychiatric 5psychiatric 6psychiatric 7psychiatric 8psychiatric 9psychiatric 10watching 2move 2move 3move 4move 5move 6move 7move 8move 9move 10intellectual 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |